BGI Genomics

Name: BGI Genomics
Address: Ole Maaløes Vej 3, Copenhagen, 2200, DK
Telephone: +4581730146

Hjem
Danmark
Copenhagen
BGI Genomics

BGI Genomics is the world’s leading integrated solutions provider of precision medicine

BGI Genomics provides academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across a broad range of applications spanning:

• Basic research covering human, plant, animal and microbial species
• Clinical research in human health
• Drug discovery and development
• Agriculture and Biodive

rsity preservation and sustainability

We have almost 20 years of genomics experience helping our customers achieve their research goals by delivering rapid, high quality results using a broad array of cost-effective, cutting-edge technologies, including our own innovative DNBSEQ™ sequencing technology.

04/09/2026

Five more days to go!

will be exhibiting at the Hong Kong Convention and Exhibition Center from September 9–12, 2026.

Visit us at Booth 3E-B15 to meet our team and explore how our sequencing and multi-omics solutions can support your research.

📅 September 9–12, 2026
📌 Booth 3E-B15
📍 Hong Kong Convention and Exhibition Center

We look forward to seeing you in Hong Kong!

02/09/2026

🌍✨ Great to be at the Annual RTG Retreat, hosted by Max Planck Institute for Evolutionary Biology.

We are honoured to join this exclusive gathering for early-career scientists. This year’s key focus addresses how evolutionary theory delivers real-world solutions across medicine, food production and wildlife conservation — fields that often work in isolation with separate methodological systems.

Christine Zhang and Zhengyu Xiao from are having dynamic discussions with cross-theme evolutionary biologists. They are tackling bottlenecks in large-scale multi-omics research, exploring how high-throughput sequencing can serve as a unified technical backbone for pathogen, conservation and medical-evolution pipelines. 🧬💬

These open conversations are truly rewarding, breaking down research silos and laying solid groundwork for future impact-driven collaborations 🚀. Thank you to everyone who connected with us — we look forward to more partnerships and future exchanges.

01/09/2026

✨ Day 2 highlights from in Florence, Italy! 🧬
This special congress marks 30 years since the Saccharomyces cerevisiae genome — the first eukaryotic genome ever decoded — was fully sequenced, bringing together the pioneers who made it happen and the scientists shaping yeast genomics today. 🎉🍷

(Jean) Chen and Shanshan Ju from are on the ground, connecting with top microbiology scientists and exchanging insights on multi-omics solutions for yeast pangenomics and functional genomics.💡

A huge thank you to the organizers and everyone who stopped by to chat. If we didn't get to meet, our door is always open — let's talk yeast, genomics, or your next big sequencing project. 👋

31/08/2026

ICG21·MP is this Saturday — and the full program is here. 🧬📋

On September 5, join us for a one-day deep dive into how multiomics is reshaping molecular pathology and precision oncology. Four thematic sessions, each led by distinguished chairs across China's leading hospitals.

What's on the agenda:
🔬 Session 1: Building Core Capabilities and Establishing Clinical Standards
📊 Session 2: Precision Tumor Classification and Multiomics Testing in Clinical Practice
🧠 Session 3: Precision Interpretation of Tumor Mutations — From EvidenceBased Frameworks to Intelligent Algorithms
🚀 Session 4: Frontier Technological Breakthroughs and Clinical Translation

If you're in oncology pathology, molecular diagnostics, or clinical genomics — this is the conversation to be part of.

📅 September 5, 2026 | Shenzhen, China
📍 Onsite + Live stream | Free registration
🔗 Full program & registration:
https://www.micecube.com/event/99IdHu/s4091655695968372

28/08/2026

"Technology is only the entry ticket."

For Hou Yong, CEO of BGI Genomics, research only creates impact through what follows the technology—namely compliance, localization, commercialization, and securing the path from product to market.

With GORTEC China, the Chinese division of the influential international platform for head & neck cancer research, BGI Genomics is advancing multi-omics technologies toward companion diagnostics (CDx) — helping China's innovative drugs, from ADCs to bispecific antibodies, accumulate evidence for global expansion.

We are building a comprehensive system for cancer management from prevention to monitoring, delivering full-cycle precision medicine solutions for patients and hospital partners.

And built on Genos, a 10-billion-parameter genomic foundation model developed with Zhejiang Lab, our AI model GeneT is already helping physicians at top-tier hospitals pinpoint rare-disease variants, with promising early results.

The goal: to advance digital health technology to reach not only a few countries and a few people — but for the benefit of all.

🎥 Full interview ↓

28/08/2026

Heading to São Luís for CBGM 2026? 🧬

On September 2–5, The ###VII Brazilian Congress of Medical Genetics and Genomics will bring together leading professionals in medical genetics, rare diseases, hereditary cancer, neonatal screening, and precision medicine — marking 40 years of the Brazilian Society of Medical Genetics and Genomics (SBGM).

Come find us at Stand 23. 👋

Let's talk about how genomic technologies can support rare disease diagnosis, hereditary cancer risk assessment, and expanded newborn screening — for Brazil and beyond.

See you in São Luís, Maranhão! 🌎

28/08/2026

🔬 How is single-cell RNA sequencing reshaping our understanding of immunity, metabolism, and disease?

In this Client Publications Collection, we spotlight four clients’ studies powered by BGI Tech’s high-throughput single-cell RNA-seq services.

🧬 Spanning metabolic immunology, cancer biology, biomaterials, and oral microbiology, these studies reveal:

• Metabolic–immune mechanisms driving MASH-HCC progression
• Immune regulators of breast cancer lung metastasis
• Cellular mechanisms supporting vascular graft regeneration
• Cellular and microbial landscapes informing periodontal therapy

💡 Together, these findings demonstrate how single-cell technologies are helping researchers uncover disease mechanisms, identify potential biomarkers and therapeutic targets, and develop new regenerative strategies.

📖 Explore the four studies in the accompanying research cards.

26/08/2026

🧬 Great deep-dive conversations at 6th International Symposium on the Nitrogen Nutrition of Plants in Gatersleben, Germany (Aug 23-27, 2026) 🌱

This premier symposium brought together global scientists to dissect genetic, molecular and physiological mechanisms of plant nitrogen nutrition and nitrogen-use efficiency.

Our team members Christine zhang and Zeyin Lu joined the event, where we connected with leading plant science experts to explore how multi-omics can illuminate crop nitrogen uptake, metabolism and complex regulatory networks 💡

We showcased our end-to-end multi-omics solutions and discussed promising collaborative opportunities to drive forward sustainable crop improvement.

Huge thanks to everyone for the inspiring technical discussions around plant nutrient research! 🤝

25/08/2026

What does it take to turn a local genomics lab in into a regional model for ?

At BGI Health Uruguay, the answer goes beyond bringing testing closer to patients. It is about building capability locally — through local talent, technical training, knowledge transfer, and laboratory infrastructure that can continue to grow within the region.

Today, the Uruguay lab supports clinics and hospitals across more than 10 countries in South and Central America, with locally delivered testing helping reduce dependence on cross-border sample shipment and shorten turnaround times.

In the third video of our Uruguay series, BGI Genomics LATAM Vice President CHEN Wenbo (Joe) and BGI Health Uruguay Technical Lab Director Esteban Hernández discuss why Uruguay was chosen, where the lab stands today, and how its role could expand across Latin America.

The full article brings all three episodes together, tracing that journey from local talent, to technology transfer, to a broader regional model for precision medicine in Latin America.

Watch the video below, and explore the full series here: https://lnkd.in/gKPpPeaN

21/08/2026

🧬 Brazil Event Recap | Connecting Prenatal Screening with Genomic Diagnosis

Last week, Genomic Summit 2026 welcomed around 150 participants in São Paulo and more than 2,000 online viewers to explore advances in genomics and precision medicine.

During his keynote, Dr. Jiale Xiang, Director of the Product Center at BGI Genomics, presented BGI Genomics’ comprehensive prenatal screening and diagnostic portfolio. Drawing on the development of NIFTY® and over a decade of implementation experience in China, he shared how genomic technologies can connect population-scale screening with advanced diagnosis.

Three representative studies supported this pathway: a 2026 Nature Health study reported that publicly funded NIPT implementation in Hebei Province achieved 93.3% coverage across more than 1.18 million tests; studies in AJOG and Prenatal Diagnosis demonstrated the potential of NIPT to identify dominant single-gene disorders; and a study of 111 fetuses with structural abnormalities found that WGS achieved a diagnostic yield of 19.8% while reducing turnaround time from 39 to 18 days.

Together, the NIFTY® series, NIFTY® Mono, CNV-seq, WES and WGS contribute to a connected pathway from early risk assessment to advanced genomic diagnosis.

Thank you to Dasa Genômica and everyone who joined us in São Paulo and online. We look forward to advancing prenatal genomic care across and together.

Adresse

Ole Maaløes Vej 3
Copenhagen
2200

Telefon

+4581730146

Internet side

https://www.bgi.com/global/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når BGI Genomics sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.